INNO-GENE SA ZY -10 (WQ3) — Cash Flow-to-Debt Ratio
INNO-GENE SA ZY -10 (WQ3) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of €54.00K could theoretically repay 0% of its total liabilities (€7.45 Million) in one year. See INNO-GENE SA ZY -10 free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
INNO-GENE SA ZY -10 Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for INNO-GENE SA ZY -10 across 4 annual periods. Also explore WQ3 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for INNO-GENE SA ZY -10 (2021–2024)
Year-by-year debt coverage analysis for INNO-GENE SA ZY -10. For market capitalisation and broader financial context, see WQ3 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.17x | €-1.13 Million | €6.50 Million | ▲ +77.9% |
| 2023 | -0.79x | €-2.49 Million | €3.16 Million | ▼ -15993.0% |
| 2022 | 0.00x | €11.00K | €2.22 Million | ▼ -99.6% |
| 2021 | 1.21x | €6.75 Million | €5.60 Million | — |